References
- Benke S, et al. 2018. Human tripartite motif protein 52 is required for cell context-dependent proliferation. Oncotarget. Mar. 2(9):13565–13581.
- Cambiaghi V, et al. 2012. TRIM proteins in cancer. Adv Exp Med Biol. 770:77–91.
- Chaluvally-Raghavan P, et al. 2016. Direct upregulation of STAT3 by MicroRNA-551b-3p deregulates growth and metastasis of ovarian cancer. Cell Rep. May. 17(15):1493–1504.
- Cho H, et al. 2013. Overexpression of glucose transporter-1 (GLUT-1) predicts poor prognosis in epithelial ovarian cancer. Cancer Investig. Nov. 31:607–615.
- Coleman RL, et al. 2013. Latest research and treatment of advanced-stage epithelial ovarian cancer. Nat Rev Clin Oncol. Apr. 10:211–224.
- Fan W, et al. 2017. TRIM52: a nuclear TRIM protein that positively regulates the nuclear factor-kappa B signaling pathway. Mol Immunol. Feb. 82:114–122.
- Furtek SL, et al. 2016. Strategies and approaches of Targeting STAT3 for cancer treatment. ACS Chem Biol. Feb. 19(11):308–318.
- Ganapathy-Kanniappan S, Geschwind JF. 2013. Tumor glycolysis as a target for cancer therapy: progress and prospects. Mol Cancer. Dec. 3(12):152.
- Gao X, et al. 2013. Reciprocal regulation of protein kinase and pyruvate kinase activities of pyruvate kinase M2 by growth signals. J Biol Chem. May 31;288:15971–15979.
- Garcia R, et al. 2001. Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells. Oncogene. May. 3(20):2499–2513.
- Hanahan D, Weinberg RA. 2011. Hallmarks of cancer: the next generation. Cell. Mar. 4(144):646–674.
- Hollis RL, Gourley C. 2016. Genetic and molecular changes in ovarian cancer. Cancer Biol Med. Jun;13:236–247.
- Huang L, et al. 2008. Improved survival time: what can survival cure models tell us about population-based survival improvements in late-stage colorectal, ovarian, and testicular cancer? Cancer. May 15;112:2289–2300.
- Jin Z, et al. 2018. TRIM14 promotes colorectal cancer cell migration and invasion through the SPHK1/STAT3 pathway. Cancer Cell Int. 18:202. Epub 2018/12/18.
- Lu YX, et al. 2018. Pharmacological Ascorbate suppresses growth of Gastric Cancer Cells with GLUT1 overexpression and enhances the efficacy of Oxaliplatin through redox modulation. Theranostics. 8:1312–1326.
- Pan S, et al. 2019. TRIM52 promotes colorectal cancer cell proliferation through the STAT3 signaling. Cancer Cell Int. 19:57.
- Saini U, et al. 2017. Elevated STAT3 expression in ovarian cancer ascites promotes invasion and metastasis: a potential therapeutic target. Oncogene. Jan 12;36:168–181.
- Sano S, et al. 2005. Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model. Nat Med. Jan;11:43–49.
- Song L, et al. 2003. Activation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small cell carcinoma cells. Oncogene. Jul 3;22:4150–4165.
- Vander Heiden MG, et al. 2009. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. May 22;324:1029–1033.
- Wang B, et al. 2018. PKM2 is involved in neuropathic pain by regulating ERK and STAT3 activation in rat spinal cord. J Headache Pain. Jan 18;19:7.
- Wen W, et al. 2014. Targeting JAK1/STAT3 signaling suppresses tumor progression and metastasis in a peritoneal model of human ovarian cancer. Mol Cancer Ther. Dec;13:3037–3048.
- Wong N, et al. 2013. PKM2, a central point of regulation in cancer metabolism. Int J Cell Biol. 2013:242513.
- Yang L, et al. 2014. PKM2 regulates the Warburg effect and promotes HMGB1 release in sepsis. Nat Commun. Jul 14;5:4436.
- Yang W, et al. 2018. TRIM52 plays an oncogenic role in ovarian cancer associated with NF-kB pathway. Cell Death Dis. Sep 5;9:908.
- Yu H, et al. 2009. STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer. Nov. 9:798–809.
- Zeng G, et al. 2019. E3-ubiquitin ligase TRIM6 aggravates myocardial ischemia/reperfusion injury via promoting STAT1-dependent cardiomyocyte apoptosis. Aging (Albany NY). 11:3536–3550. Epub 2019/06/07.
- Zhang C, et al. 2017. TRIM8 regulates stemness in glioblastoma through PIAS3-STAT3. Mol Oncol. Mar;11:280–294. Epub 2017/01/19.
- Zhang Y, et al. 2018. TRIM52 up-regulation in hepatocellular carcinoma cells promotes proliferation, migration and invasion through the ubiquitination of PPM1A. Journal of Experimental & Clinical Cancer Research: CR. Jun 13;37:116.
- Zhong LX, et al. 2015. Inhibition of STAT3 signaling as critical molecular event in resveratrol-suppressed ovarian cancer cells. J Ovarian Res. Apr 22;8:25.